In line, the comparison of 1585 ZZ AAT deficient subjects from Swedish AAT Deficiency Register and 5,999 population-based controls showed that death due to cancer in general was lower among ZZ individuals compared to the controls, i.e. 11% versus 33%. Here, SERPINA1 is linked to alpha 1-antitrypsin deficiency.